Kumaravel found that C-DIM reduced PSPC1-mediated TGFβ cancer-promoting activity by inhibiting NR4A1, the upstream regulator of PSPC1 (57) Summary of the main targeted drugs is shown in Table 1. Here, NR4A1 is linked to cancer.